Center for Global Health R&D Policy Assessment

Follow us on:

Blogs tagged: TB

Aarthi Rao
Posted by Aarthi Rao
Sep 16 2011

Point-of-Care Diagnostics for TB—The Devil’s in the Details

Reflections from recent conference, "TB Diagnostics in India: From importation and imitation to innovation"

Recently, I attended a conference in Bangalore, “TB Diagnostics in India: From importation and imitation to innovation” that brought together a diverse group that included public researchers, firms, venture capitalists, international donors and others to discuss the need for better TB diagnostics and the role that Indian firms might play in developing them.

Nora Engel
Posted by Nora Engel
Sep 13 2011

Challenges for Innovation in TB Diagnostics

Lessons from a recent conference in Bangalore, India

A guest blog by Nora Engel and Madhukar Pai

Jennifer Woolley
Posted by Jennifer Woolley
Aug 8 2011

Dedicated to Developing New TB Vaccines for the World

Part two of the PDP mini-series: Guest blog from Aeras

Aeras Logo

This is the second part to our Product Development Partnership (PDP) mini-series. Here, Jennifer Woolley from Aeras discusses their PDP experience with tuberculosis vaccine development.

Tuberculosis is known as a disease of poverty.

Amrita Palriwala
Posted by Amrita Palriwala
Dec 15 2010

Can prizes spur medical innovation for TB and other neglected diseases?

This post first appeared December 1st, 2010 as a guest post on NextBillion.net a website and blog community of business leaders, social entrepreneurs, NGOs, policy makers and academics focusing on the connection between development and enterprise.

Kaitlin Christenson
Posted by Kaitlin Christenson
Oct 26 2010

Do prizes offer enough incentive to drive global health product development?

A Guest Blog by Kaitlin Christenson, Coalition Manager for Global Health Technologies Coalition

Results for Development guest blogger Kaitlin Christenson describes the R4D event "The Role of Prizes in Global Health R&D," a webinar and meeting held October 20th in Washington DC. The event brought together over 30 participants from North America, Europe, and Africa, including U.S. government officials, academics, NGOs, and private companies and foundations, to discuss R4D’s preliminary results from its study on prizes.

Do prizes offer enough incentive to drive global health product development?